New pill to enable safer promiscuity
from Christian Concern:
A new HIV prevention drug is to be provided by the NHS from September.
NHS England announced that Pre-exposure prophylaxis, also known as PrEP will be made available to sexual health clinics across the UK. In an initial 3 year trial a minimum of 10,000 individuals will be offered the drug.
Ian Green, CEO of Terrence Higgins Trust says: “The priority must now be to make sure that the trial reaches everyone at risk of HIV, and that it is rolled out speedily across the whole country, by the end of this year at the very latest. Spring 2018 is not soon enough. Now that the PrEP trial drug has been procured, we’re well on the way to protecting over 10,000 people at risk of HIV.
“To make sure no-one at risk of HIV is left behind, it is crucial that at the end of this trial in three years time, a clear process for routinely commissioning PrEP on the NHS is agreed.”
Deborah Gold, chief executive at NAT (National AIDS Trust) said: “We already know that PrEP brings down rates of HIV infection, changing lives for those at risk and saving public money. We now need to work with NHS England, local authorities, and the sexual health sector to make sure the widest possible range of eligible people at high risk of HIV have access to the trial.
“We will continue to monitor the uptake of PrEP, aiming to learn as much as possible about how to get PrEP to all those who need it most. This is a pivotal moment in the fight against HIV. PrEP, if targeted properly at those in need and at high risk of HIV, offers the possibility of transforming the English HIV epidemic.
“From September, people at high risk of HIV will have access via the NHS in England to an empowering new tool that is truly individual controlled and not subject to negotiation with a partner, leading to the improvement of many, many lives.”
Related Posts
Tags
Share This
